1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Brazil Infectious Diagnostics Market Outlook to 2021

Brazil Infectious Diagnostics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 39 pages

Brazil Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "Brazil Infectious Diagnostics Market Outlook to 2021", provides key market data on the Brazil Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Brazil Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Brazil Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Infectious Diagnostics Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Infectious Diagnostics Market, Brazil 7
3.1 Infectious Diagnostics Market, Brazil, Revenue ($m), 2007-2014 7
3.2 Infectious Diagnostics Market, Brazil, Revenue ($m), 2014-2021 9
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), by Segment, 2014-2021 13
3.3 Infectious Diagnostics Market, Brazil, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Infectious Diagnostics Market, Brazil, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in Brazil, Infectious Diagnostics Market 18
4.1 Abbott Laboratories 18
4.1.1 Company Overview 18
4.2 Siemens Healthcare 18
4.2.1 Company Overview 18
4.3 F. Hoffmann-La Roche Ltd. 18
4.3.1 Company Overview 18
4.4 Qiagen N.V. 19
4.4.1 Company Overview 19
4.5 bioMerieux S.A. 19
4.5.1 Company Overview 19
4.6 DiaSorin S.p.A 19
4.6.1 Company Overview 19
4.7 Alere Inc. 20
4.7.1 Company Overview 20
5 Infectious Diagnostics Market Pipeline Products 21
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 33
6.1.2 Globavir Enters into Co-Development Agreement with Biomanguinhos 34
7 Recent Developments 35
7.1 Strategy And Business Planning 35
7.1.1 Oct 22, 2014: ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics 35
8 Appendix 36
8.1 Research Methodology 37
8.1.1 Coverage 37
8.1.2 Secondary Research 37
8.1.3 Primary Research 37
8.1.4 Company Share Analysis 38
8.1.5 Distribution Share Analysis 38
8.2 GlobalData Consulting 38
8.3 Contact Us 38
8.4 Disclaimer 39

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Infectious Diagnostics Market, Brazil, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Infectious Diagnostics Market, Brazil, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Infectious Diagnostics Market Pipeline Products 21
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 33
Table 9: Globavir Enters into Co-Development Agreement with Biomanguinhos 34

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Infectious Diagnostics Rapid Tests and POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Infectious Diagnostics Market, Brazil, Company Share (%) 2014 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021

In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global IVD market is projected to reach USD 78.74 billion by 2021, at a CAGR of 5.5% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the increasing prevalence ...

Immunoassay Market by Product & Service, Technique, Application, End User - Global Forecast to 2021

Immunoassay Market by Product & Service, Technique, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...


Download Unlimited Documents from Trusted Public Sources

Global Point Of Care Testing Industry - Forecast

  • October 2016
    77 pages
  • Point Of Care T...  

    Cardiovascular ...  

    Heart Attack  

  • World  

    Europe  

    United Kingdom  

View report >

In Vitro Diagnostic Reagent Industry in Australia

  • September 2016
    102 pages
  • In Vitro Diagno...  

    Serology  

  • Australia  

    United States  

View report >

Influenza Statistics in the US

  • August 2016
    43 pages
  • Influenza  

    In Vitro Diagno...  

    Therapy  

  • United States  

    North America  

View report >

Related Market Segments :

Rapid Test
Point Of Care Testing
Diagnostics

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.